Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice.

Evid Based Complement Alternat Med · 2022 · PMC8933113 · PMID 35310032

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

extremely significantP < 0.01actually significant

Compared with the model group, the bone marrow DNA content in the G-Re group was significantly greater, and the difference was extremely significant ( P < 0.01).

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.